Lupus & antiphospholipid syndrome

Pregnancy Outcomes in Patients With Interstitial Lung Disease

Arthritis Care Res (Hoboken)Published Retrospective cohort study

Authors' conclusion

Although APOs were common in women with very severe ILD and underlying CTD, overall maternal morbidity and mortality were low.

Study context

Population
Pregnancies in patients with interstitial lung disease (ILD) with underlying autoimmune disease, Duke University Health System; 85% Black, 71% sarcoidosis, 29% CTD-ILDpregnancies in 60 women
Participants
86 pregnancies
Exposure
Pregnancies by ILD severity on pulmonary function tests (PFTs) and by underlying disease
Outcome
Adverse pregnancy outcomes (APOs) defined by PROMISSE-APO and Severe PROMISSE-APO criteria
Methodological detailssingle health system (Duke University Health System), medical record review
  • Single health system (Duke University Health System)
  • Medical record review

Main finding

As reported in the abstract

PROMISSE-APOs

Very severe ILD

all pregnancies

CTD-ILD

56%

Sarcoidosis

23%

Very severe ILD: P = 0.02 across severity groups · CTD-ILD vs Sarcoidosis: P = 0.02

PROMISSE-APOs, all pregnancies
32%

Observational data: associations, not effects.

Further findings

OutcomeValues
Severe PROMISSE-APOsVery severe ILD 60% · CTD-ILD 28%
ILD severity among pregnancies with available PFTs (n = 59)Very severe ILD 12% · Severe ILD 25% · Mild-moderate ILD 51% · Normal lung function 12%
Severe PROMISSE-APOs — Severe PROMISSE-APOs, all pregnancies
15%

Maternal morbidity and mortality

Maternal deaths
0
ICU stay during pregnancy
1
Volume overload after delivery, resolved with medical management
3
Oxygen during delivery
7
Intubated
0

Original publication

Pregnancy Outcomes in Patients With Interstitial Lung Disease. Arthritis Care Res (Hoboken). Published 4 March 2023. doi:10.1002/acr.24814

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.